EUVIMEDEUVIMED entdecken
Open Access

Assessing and engineering the IscB–ωRNA system for programmed genome editing

Hao Yan, Xiaoqing Tan, Siyuan Zou, Yihong Sun, Ailong Ke, Weixin Tang

Nature Chemical Biology · 2024

DOI: 10.1038/s41589-024-01669-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Chemical Biology, 2024. Verfasst von Hao Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Gene Editing. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, David and Lucile Packard Foundation (David & Lucile Packard Foundation), American Cancer Society (American Cancer Society, Inc.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OMEGA RNA (ωRNA)-guided endonuclease IscB, the evolutionary ancestor of Cas9, is an attractive system for in vivo genome editing because of its compact size and mechanistic resemblance to Cas9. However, wild-type IscB-ωRNA systems show limited activity in human cells. Here we report enhanced OgeuIscB, which, with eight amino acid substitutions, displayed a fourfold increase in in vitro DNA-binding affinity and a 30.4-fold improvement in insertion-deletion (indel) formation efficiency in human cells. Paired with structure-guided ωRNA engineering, the enhanced OgeuIscB-ωRNA systems efficiently edited the human genome across 26 target sites, attaining up to 87.3% indel and 62.2% base-editing frequencies. Both wild-type and engineered OgeuIscB-ωRNA showed moderate fidelity in editing the human genome, with off-target profiles revealing key determinants of target selection including an NARR target-adjacent motif (TAM) and the TAM-proximal 14 nucleotides in the R-loop. Collectively, our engineered OgeuIscB-ωRNA systems are programmable, potent and sufficiently specific for human genome editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingHumansGenome, HumanRNA, Guide, CRISPR-Cas SystemsHEK293 CellsCRISPR-Cas SystemsRNAEndonucleasesGenetic EngineeringBacterial ProteinsDNAINDEL Mutation

Substanzen

RNA, Guide, CRISPR-Cas SystemsRNAEndonucleasesBacterial ProteinsDNA

Autor:innen und Institutionen

  • Department of Chemistry, The University of Chicago, Chicago, IL, USA.
  • Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
  • Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
  • Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA. ailong.ke@yale.edu.
  • Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA. ailong.ke@yale.edu.
  • Department of Chemistry, The University of Chicago, Chicago, IL, USA. weixintang@uchicago.edu.

Förderung

  • NIGMS NIH HHS
  • David and Lucile Packard Foundation (David & Lucile Packard Foundation)
  • American Cancer Society (American Cancer Society, Inc.)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)

Zitieren

APA

Yan, H., Tan, X., Zou, S., Sun, Y., Ke, A., & Tang, W. (2024). Assessing and engineering the IscB–ωRNA system for programmed genome editing. Nature Chemical Biology. https://doi.org/10.1038/s41589-024-01669-3

Vancouver

Yan H, Tan X, Zou S, Sun Y, Ke A, Tang W. Assessing and engineering the IscB–ωRNA system for programmed genome editing. Nature Chemical Biology. 2024. doi:10.1038/s41589-024-01669-3

BibTeX
@article{Yan2024,
  author = {Yan, Hao and Tan, Xiaoqing and Zou, Siyuan and Sun, Yihong and Ke, Ailong and Tang, Weixin},
  title = {Assessing and engineering the IscB–ωRNA system for programmed genome editing},
  journal = {Nature Chemical Biology},
  year = {2024},
  doi = {10.1038/s41589-024-01669-3}
}
Kostenlos starten →